Interleukin-5	B-protein
signaling	O
in	O
human	B-cell_type
eosinophils	I-cell_type
involves	O
JAK2	B-protein
tyrosine	I-protein
kinase	I-protein
and	O
Stat1	B-protein
alpha	I-protein
.	O

Signaling	O
by	O
a	O
wide	O
variety	O
of	O
cytokines	B-protein
,	O
including	O
interferons	B-protein
,	O
interleukins	B-protein
,	O
and	O
growth	B-protein
factors	I-protein
,	O
involves	O
activation	O
of	O
JAK	B-protein
kinases	I-protein
and	O
Stat	B-protein
(	I-protein
Signal	I-protein
transducers	I-protein
and	I-protein
activators	I-protein
of	I-protein
transcription	I-protein
)	I-protein
proteins	I-protein
.	O

At	O
present	O
,	O
not	O
much	O
is	O
known	O
about	O
the	O
molecular	O
mechanisms	O
by	O
which	O
interleukin-5	B-protein
(	O
IL-5	B-protein
)	O
exerts	O
its	O
diverse	O
biologic	O
effects	O
.	O

Human	B-cell_type
eosinophils	I-cell_type
are	O
one	O
of	O
the	O
most	O
important	O
target	B-cell_type
cells	I-cell_type
for	O
IL-5	B-protein
and	O
were	O
used	O
here	O
to	O
study	O
IL-5	B-protein
signaling	O
in	O
a	O
primary	B-cell_type
human	I-cell_type
cell	I-cell_type
.	O

IL-5	B-protein
induced	O
rapid	O
and	O
transient	O
tyrosine	O
phosphorylation	O
of	O
JAK2	B-protein
.	O

Moreover	O
,	O
IL-5	B-protein
induced	O
at	O
least	O
two	O
DNA-binding	B-protein
complexes	I-protein
,	O
using	O
nuclear	O
extracts	O
from	O
normal	O
human	B-cell_type
eosinophils	I-cell_type
and	O
the	O
IL-6/interferon-gamma	B-DNA
response	I-DNA
element	I-DNA
of	O
the	O
ICAM-1	B-DNA
promoter	I-DNA
(	O
ICAM-1	B-DNA
pIRE	I-DNA
)	O
in	O
an	O
electromobility	O
shift	O
assay	O
.	O

From	O
supershift	O
experiments	O
it	O
was	O
concluded	O
that	O
one	O
DNA-binding	B-protein
complex	I-protein
contained	O
Stat1	B-protein
alpha	I-protein
,	O
probably	O
as	O
a	O
homodimer	O
.	O

Both	O
DNA-binding	B-protein
complexes	I-protein
were	O
inhibited	O
by	O
a	O
phosphotyrosine	B-protein
antibody	I-protein
(	O
4G10	B-protein
)	O
,	O
suggesting	O
that	O
tyrosine	O
phosphorylation	O
is	O
required	O
for	O
complex	O
formation	O
.	O

IL-3	B-protein
and	O
granulocyte-macrophage	B-protein
colony-stimulating	I-protein
factor	I-protein
induced	O
,	O
similar	O
to	O
IL-5	B-protein
,	O
two	O
DNA-binding	B-protein
complexes	I-protein
in	O
human	B-cell_type
eosinophils	I-cell_type
,	O
including	O
Stat1	B-protein
alpha	I-protein
.	O

These	O
data	O
show	O
for	O
the	O
first	O
time	O
that	O
molecular	O
mechanisms	O
of	O
IL-5	B-protein
signaling	O
in	O
human	B-cell_type
eosinophils	I-cell_type
involve	O
members	O
of	O
the	O
JAK	B-protein
kinase	I-protein
family	I-protein
as	O
well	O
as	O
members	O
of	O
the	O
Stat	B-protein
family	I-protein
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

RAPID	NULL
COMMUNICATION	NULL
Interleukin-5	NULL
Signaling	NULL
in	NULL
Human	NULL
Eosinophils	NULL
Involves	NULL
JAK2	NULL
Tyrosine	NULL
Kinase	NULL
and	NULL
Statla	NULL
By	NULL
Tiomme	NULL
van	NULL
der	NULL
Bruggen	NULL
,	NULL
Eric	NULL
Caldenhoven	NULL
,	NULL
Deon	NULL
Kanters	NULL
,	NULL
Paul	NULL
Coffer	NULL
,	NULL
Jan	NULL
A.M.	NULL
Raaijmakers	NULL
,	NULL
Jan-Willem	NULL
J.	NULL
Lammers	NULL
,	NULL
and	NULL
Leo	NULL
Koenderman	NULL
Signaling	NULL
by	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
cytokines	NULL
,	NULL
including	NULL
interferons	NULL
,	NULL
interleukins	NULL
,	NULL
and	NULL
growth	NULL
factors	NULL
,	NULL
involves	NULL
activation	NULL
of	NULL
JAK	NULL
kinases	NULL
and	NULL
Stat	NULL
(	NULL
Signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
}	NULL
proteins	NULL
.	NULL

At	NULL
present	NULL
,	NULL
not	NULL
much	NULL
is	NULL
known	NULL
about	NULL
the	NULL
molecular	NULL
mechanisms	NULL
by	NULL
which	NULL
interleukin-5	NULL
(	NULL
IL-5	NULL
)	NULL
exerts	NULL
its	NULL
diverse	NULL
biologic	NULL
effects	NULL
.	NULL

Human	NULL
eosinophils	NULL
are	NULL
one	NULL
of	NULL
the	NULL
most	NULL
important	NULL
target	NULL
cells	NULL
for	NULL
IL-5	NULL
and	NULL
were	NULL
used	NULL
here	NULL
to	NULL
study	NULL
IL-5	NULL
signaling	NULL
in	NULL
a	NULL
primary	NULL
human	NULL
cell	NULL
.	NULL

IL-5	NULL
induced	NULL
rapid	NULL
and	NULL
transient	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK2	NULL
.	NULL

Moreover	NULL
,	NULL
IL-5	NULL
induced	NULL
at	NULL
least	NULL
two	NULL
DNA-binding	NULL
complexes	NULL
,	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
normal	NULL
human	NULL
eosinophils	NULL
and	NULL
the	NULL
IL-6/interferon-y	NULL
response	NULL
element	NULL
of	NULL
the	NULL
ICAM-1	NULL
promotor	NULL
{	NULL
ICAM-1	NULL
pIRE	NULL
)	NULL
in	NULL
an	NULL
electromobility	NULL
shift	NULL
UMAN	NULL
EOSINOPHILS	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
allergic	NULL
diseases	NULL
such	NULL
as	NULL
allergic	NULL
asthma	NULL
.	NULL
'	NULL

From	NULL
in	NULL
vitro	NULL
experiments	NULL
it	NULL
has	NULL
been	NULL
established	NULL
that	NULL
eosinophil	NULL
functioning	NULL
,	NULL
as	NULL
well	NULL
as	NULL
expression	NULL
of	NULL
cell	NULL
surface	NULL
proteins	NULL
,	NULL
can	NULL
be	NULL
induced	NULL
or	NULL
increased	NULL
by	NULL
several	NULL
cytokines	NULL
such	NULL
as	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
,	NULL
IL-3	NULL
,	NULL
IL-4	NULL
,	NULL
IL-5	NULL
,	NULL
IL-8	NULL
,	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
(	NULL
TNF-a	NULL
)	NULL
,	NULL
or	NULL
interferon-y	NULL
(	NULL
IFN-y	NULL
)	NULL
.	NULL

>	NULL
*	NULL
IL-5	NULL
is	NULL
of	NULL
special	NULL
interest	NULL
,	NULL
because	NULL
it	NULL
is	NULL
the	NULL
terminal	NULL
differentiation	NULL
factor	NULL
for	NULL
eosinophils	NULL
.	NULL
``	NULL

Several	NULL
lines	NULL
of	NULL
evidence	NULL
suggest	NULL
that	NULL
eosinophil	NULL
functions	NULL
are	NULL
also	NULL
modulated	NULL
in	NULL
vivo	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
the	NULL
phenotype	NULL
of	NULL
eosinophils	NULL
isolated	NULL
from	NULL
the	NULL
peripheral	NULL
blood	NULL
of	NULL
allergic	NULL
asthmatic	NULL
subjects	NULL
resembles	NULL
the	NULL
IL-5-primed	NULL
(	NULL
preactivated	NULL
)	NULL
phenotype	NULL
in	NULL
a	NULL
chemotaxis	NULL
assay	NULL
.	NULL

'*	NULL
``	NULL
'	NULL
Eosinophils	NULL
obtained	NULL
from	NULL
a	NULL
bron-choalveolar	NULL
lavage	NULL
(	NULL
BAL	NULL
)	NULL
from	NULL
allergen-challenged	NULL
allergic	NULL
asthmatics	NULL
have	NULL
a	NULL
changed	NULL
expression	NULL
of	NULL
multiple	NULL
adhesion	NULL
molecules	NULL
,	NULL
indicating	NULL
an	NULL
activated	NULL
phenotype	NULL
.	NULL
``	NULL

IL-5	NULL
is	NULL
a	NULL
rather	NULL
selective	NULL
cytokine	NULL
,	NULL
because	NULL
the	NULL
IL-5	NULL
receptor	NULL
is	NULL
expressed	NULL
on	NULL
a	NULL
limited	NULL
number	NULL
of	NULL
hemopoietic	NULL
cells	NULL
,	NULL
ie	NULL
,	NULL
eosinophils	NULL
,	NULL
basophils	NULL
,	NULL
and	NULL
some	NULL
B	NULL
cells	NULL
.	NULL
``	NULL

High-affinity	NULL
receptors	NULL
for	NULL
IL-5	NULL
,	NULL
IL-3	NULL
,	NULL
and	NULL
GM-CSF	NULL
are	NULL
composed	NULL
of	NULL
a	NULL
unique	NULL
-subunit	NULL
and	NULL
a	NULL
common	NULL
#	NULL
-subunit	NULL
.	NULL

'*	NULL
``	NULL
The	NULL
3-subunit	NULL
is	NULL
important	NULL
for	NULL
cytokine	NULL
signaling	NULL
and	NULL
these	NULL
cytokines	NULL
,	NULL
as	NULL
one	NULL
might	NULL
expect	NULL
,	NULL
have	NULL
similar	NULL
effects	NULL
on	NULL
eosinophils	NULL
.	NULL
``	NULL

From	NULL
the	NULL
Department	NULL
of	NULL
Pulmonary	NULL
Diseases	NULL
,	NULL
University	NULL
Hospital	NULL
Utrecht	NULL
,	NULL
and	NULL
the	NULL
Hubrecht	NULL
Laboratory	NULL
,	NULL
Netherlands	NULL
Institute	NULL
for	NULL
Developmental	NULL
Biology	NULL
,	NULL
Utrecht	NULL
,	NULL
The	NULL
Netherlands	NULL
.	NULL

Submitted	NULL
September	NULL
26	NULL
,	NULL
1994	NULL
;	NULL
accepted	NULL
December	NULL
20	NULL
,	NULL
1994	NULL
.	NULL

Supported	NULL
by	NULL
a	NULL
research	NULL
grant	NULL
from	NULL
GLAXO	NULL
by	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Leo	NULL
Koenderman	NULL
,	NULL
PhD	NULL
,	NULL
Department	NULL
of	NULL
Pulmonary	NULL
Diseases	NULL
,	NULL
University	NULL
Hospital	NULL
Utrecht	NULL
,	NULL
PO	NULL
Box	NULL
85500	NULL
,	NULL
3508	NULL
GA	NULL
Utrecht	NULL
,	NULL
The	NULL
Netherlands	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
'	NULL
``	NULL
advertisement	NULL
``	NULL
'	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-497	NULL
1/95/8506-0038	NULL
$	NULL
3.00/0	NULL
1442	NULL
assay	NULL
.	NULL

From	NULL
supershift	NULL
experiments	NULL
it	NULL
was	NULL
concluded	NULL
that	NULL
one	NULL
DNA-binding	NULL
complex	NULL
contained	NULL
Statia	NULL
«	NULL
,	NULL
probably	NULL
as	NULL
a	NULL
homodimer	NULL
.	NULL

Both	NULL
DNA-binding	NULL
complexes	NULL
were	NULL
inhibited	NULL
by	NULL
a	NULL
phosphotyrosine	NULL
antibody	NULL
(	NULL
4G10	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
tyrosine	NULL
phosphorylation	NULL
is	NULL
required	NULL
for	NULL
complex	NULL
formation	NULL
.	NULL

IL-3	NULL
and	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
in-duced	NULL
,	NULL
similar	NULL
to	NULL
IL-5	NULL
,	NULL
two	NULL
DNA-binding	NULL
complexes	NULL
in	NULL
human	NULL
eosinophils	NULL
,	NULL
including	NULL
Statie	NULL
.	NULL

These	NULL
data	NULL
show	NULL
for	NULL
the	NULL
first	NULL
time	NULL
that	NULL
molecular	NULL
mechanisms	NULL
of	NULL
IL-5	NULL
signaling	NULL
in	NULL
human	NULL
eosinophils	NULL
involve	NULL
members	NULL
of	NULL
the	NULL
JAK	NULL
kinase	NULL
family	NULL
as	NULL
well	NULL
as	NULL
members	NULL
of	NULL
the	NULL
Stat	NULL
family	NULL
.	NULL

©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

Tested	NULL
on	NULL
a	NULL
variety	NULL
of	NULL
cells	NULL
,	NULL
IL-5	NULL
,	NULL
IL-3	NULL
,	NULL
and	NULL
GM-CSF	NULL
have	NULL
several	NULL
effects	NULL
,	NULL
such	NULL
as	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
multiple	NULL
cellular	NULL
substrates	NULL
,	NULL
including	NULL
the	NULL
3-subunit	NULL
of	NULL
the	NULL
IL-5/IL-3/	NULL
GM-CSF	NULL
receptors	NULL
and	NULL
Shc	NULL
,	NULL
and	NULL
activation	NULL
of	NULL
p21	NULL
ras	NULL
and	NULL
MAP	NULL
kinase	NULL
.	NULL

*'*	NULL
``	NULL
Some	NULL
tyrosine	NULL
kinases	NULL
have	NULL
been	NULL
identified	NULL
that	NULL
are	NULL
activated	NULL
by	NULL
IL-3	NULL
and	NULL
GM-CSF	NULL
,	NULL
eg	NULL
,	NULL
the	NULL
proto-oncogene	NULL
product	NULL
c-fps/fes	NULL
and	NULL
lyn	NULL
kinase	NULL
.	NULL
``	NULL

JAK2	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
Janus	NULL
family	NULL
of	NULL
tyrosine	NULL
kinases	NULL
(	NULL
JAK	NULL
kinases	NULL
)	NULL
,	NULL
is	NULL
also	NULL
activated	NULL
by	NULL
IL-3	NULL
and	NULL
GM-CSF	NULL
.	NULL

``	NULL
**	NULL
``	NULL
JAK	NULL
kinases	NULL
play	NULL
a	NULL
central	NULL
role	NULL
in	NULL
signaling	NULL
by	NULL
several	NULL
cytokines	NULL
,	NULL
including	NULL
interferons	NULL
,	NULL
interleukins	NULL
,	NULL
and	NULL
growth	NULL
factors	NULL
.	NULL
``	NULL

''	NULL
The	NULL
JAK	NULL
kinase	NULL
family	NULL
comprises	NULL
at	NULL
least	NULL
four	NULL
members	NULL
,	NULL
ie	NULL
,	NULL
JAK1	NULL
,	NULL
JAK2	NULL
,	NULL
JAK3	NULL
,	NULL
and	NULL
TYK2	NULL
.	NULL
``	NULL

''	NULL
Activation	NULL
of	NULL
JAK	NULL
kinases	NULL
is	NULL
important	NULL
for	NULL
the	NULL
subsequent	NULL
activation	NULL
of	NULL
members	NULL
of	NULL
the	NULL
Stat	NULL
(	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
)	NULL
family	NULL
,	NULL
a	NULL
rapidly	NULL
expanding	NULL
family	NULL
comprising	NULL
Statla	NULL
«	NULL
,	NULL
Stat18	NULL
,	NULL
Stat2	NULL
,	NULL
Stat3	NULL
,	NULL
Stat4	NULL
,	NULL
and	NULL
mammary	NULL
gland	NULL
fac-tor	NULL
.	NULL

``	NULL
*	NULL
>	NULL
``	NULL
IFN-a-induced	NULL
activation	NULL
of	NULL
the	NULL
interferon-stimu-lated	NULL
gene	NULL
factor-3	NULL
complex	NULL
(	NULL
composed	NULL
of	NULL
Statie	NULL
,	NULL
Stat1B	NULL
,	NULL
Stat2	NULL
,	NULL
and	NULL
p48	NULL
)	NULL
requires	NULL
JAK	NULL
1	NULL
and	NULL
TYK2	NULL
,	NULL
whereas	NULL
activation	NULL
of	NULL
Statlae	NULL
by	NULL
IFN-y	NULL
is	NULL
dependent	NULL
on	NULL
JAK1	NULL
and	NULL
JAK2	NULL
.	NULL
``	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
investigated	NULL
whether	NULL
members	NULL
of	NULL
the	NULL
JAK	NULL
kinase	NULL
family	NULL
are	NULL
involved	NULL
in	NULL
IL-5	NULL
signaling	NULL
.	NULL

Fur-thermore	NULL
,	NULL
it	NULL
was	NULL
tested	NULL
if	NULL
IL-5	NULL
could	NULL
induce	NULL
DNA-binding	NULL
complexes	NULL
,	NULL
containing	NULL
proteins	NULL
that	NULL
possibly	NULL
share	NULL
homology	NULL
with	NULL
members	NULL
of	NULL
the	NULL
Stat	NULL
family	NULL
.	NULL

We	NULL
found	NULL
that	NULL
JAK2	NULL
was	NULL
phosphorylated	NULL
on	NULL
tyrosine	NULL
upon	NULL
IL-5	NULL
treatment	NULL
of	NULL
eosinophils	NULL
.	NULL

Using	NULL
the	NULL
IL-6/IFN-y	NULL
response	NULL
element	NULL
of	NULL
the	NULL
ICAM-1	NULL
promotor	NULL
(	NULL
ICAM-1	NULL
pIRE	NULL
)	NULL
,	NULL
``	NULL
we	NULL
found	NULL
that	NULL
IL-5	NULL
,	NULL
IL-3	NULL
,	NULL
and	NULL
GM-CSF	NULL
induced	NULL
at	NULL
least	NULL
two	NULL
DNA-binding	NULL
complexes	NULL
.	NULL

One	NULL
of	NULL
these	NULL
DNA-binding	NULL
complexes	NULL
contained	NULL
Stati	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Reagents	NULL
.	NULL

-	NULL
Ficoll-paque	NULL
,	NULL
Percoll	NULL
,	NULL
and	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
Pharmacia	NULL
(	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
.	NULL

Recombinant	NULL
human	NULL
IL-5	NULL
was	NULL
a	NULL
kind	NULL
gift	NULL
of	NULL
Dr	NULL
D.	NULL
Fattah	NULL
(	NULL
GLAXO	NULL
Group	NULL
Research	NULL
,	NULL
Greenford	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

Recombinant	NULL
human	NULL
IL-3	NULL
and	NULL
GM-CSF	NULL
were	NULL
obtained	NULL
from	NULL
Genzyme	NULL
(	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Oligonucleotides	NULL
used	NULL
in	NULL
this	NULL
study	NULL
were	NULL
the	NULL
ICAM-l	NULL
pIRE	NULL
(	NULL
5'-agettaggTTTCCGGGAAAgcac-3	NULL
'	NULL
)	NULL
and	NULL
a	NULL
mutant	NULL
ICAM-1	NULL
pIRE	NULL
(	NULL
5'-aggegegaggTTAGCGGTCAAgcag-	NULL
Blood	NULL
,	NULL
Vol	NULL
85	NULL
,	NULL
No	NULL
6	NULL
(	NULL
March	NULL
15	NULL
)	NULL
,	NULL
1995	NULL
:	NULL
pp	NULL
1442-1448	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

IL-5	NULL
SIGNALING	NULL
IN	NULL
HUMAN	NULL
EOSINOPHILS	NULL
cacege-3	NULL
'	NULL
)	NULL
.	NULL

All	NULL
other	NULL
materials	NULL
were	NULL
reagent	NULL
grade	NULL
.	NULL

Cell	NULL
incubations	NULL
were	NULL
performed	NULL
in	NULL
HEPES	NULL
buffer	NULL
,	NULL
containing	NULL
132	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
6.0	NULL
mmol/L	NULL
KCI	NULL
,	NULL
1.0	NULL
mmol/L	NULL
CaCl	NULL
;	NULL
1.0	NULL
mmol/L	NULL
MgSO	NULL
,	NULL
1.2	NULL
mmol/	NULL
L	NULL
potassium	NULL
phosphate	NULL
,	NULL
20	NULL
mmol/L	NULL
HEPES	NULL
,	NULL
5	NULL
mmol/L	NULL
glucose	NULL
,	NULL
and	NULL
0.5	NULL
%	NULL
human	NULL
serum	NULL
albumin	NULL
(	NULL
HSA	NULL
;	NULL
wt/vol	NULL
)	NULL
,	NULL
pH	NULL
7.4	NULL
.	NULL

Antibodies	NULL
.	NULL

-	NULL
Antiphosphotyrosine	NULL
monoclonal	NULL
antibody	NULL
(	NULL
MoAb	NULL
;	NULL
mouse	NULL
IgG2bx	NULL
,	NULL
hybridoma	NULL
4G10	NULL
)	NULL
,	NULL
anti-JAK2	NULL
,	NULL
and	NULL
anti-TYK2	NULL
polyclonal	NULL
rabbit	NULL
antiserum	NULL
were	NULL
obtained	NULL
from	NULL
UBI	NULL
(	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

MoAb	NULL
(	NULL
mouse	NULL
IgG1	NULL
)	NULL
directed	NULL
against	NULL
Stat91/84	NULL
(	NULL
Statla/	NULL
$	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Transduction	NULL
Laboratories	NULL
(	NULL
Lexington	NULL
,	NULL
KY	NULL
)	NULL
.	NULL

Anti-Stat91	NULL
(	NULL
Statla	NULL
)	NULL
polyclonal	NULL
rabbit	NULL
antiserum	NULL
raised	NULL
against	NULL
the	NULL
36	NULL
COOH-terminal	NULL
amino	NULL
acids	NULL
unique	NULL
to	NULL
Statla	NULL
was	NULL
a	NULL
kind	NULL
gift	NULL
of	NULL
Dr	NULL
C.	NULL
Schindler	NULL
(	NULL
Columbia	NULL
University	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Isolation	NULL
of	NULL
human	NULL
eosinophils	NULL
.	NULL

-	NULL
Blood	NULL
from	NULL
healthy	NULL
volunteers	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
the	NULL
Bloodbank	NULL
of	NULL
Utrecht	NULL
,	NULL
The	NULL
Netherlands	NULL
.	NULL

Mixed	NULL
granulocytes	NULL
were	NULL
isolated	NULL
from	NULL
the	NULL
buffy	NULL
coat	NULL
of	NULL
500	NULL
mL	NULL
blood	NULL
anticoagulated	NULL
with	NULL
0.4	NULL
%	NULL
trisodium	NULL
citrate	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
as	NULL
described	NULL
before	NULL
.	NULL
``	NULL

The	NULL
granulocyte	NULL
fraction	NULL
was	NULL
centrifuged	NULL
for	NULL
20	NULL
minutes	NULL
at	NULL
room	NULL
temperature	NULL
over	NULL
Percoll	NULL
(	NULL
density	NULL
,	NULL
1.084	NULL
g/mL	NULL
;	NULL
layered	NULL
on	NULL
percoll	NULL
with	NULL
a	NULL
density	NULL
of	NULL
1.1	NULL
g/mL	NULL
)	NULL
to	NULL
reduce	NULL
the	NULL
number	NULL
of	NULL
neutrophils	NULL
.	NULL

The	NULL
eosinophil	NULL
enriched	NULL
fraction	NULL
was	NULL
collected	NULL
from	NULL
the	NULL
percoll	NULL
1.084/1.1	NULL
interface	NULL
.	NULL

Eosinophils	NULL
were	NULL
subsequently	NULL
isolated	NULL
by	NULL
the	NULL
method	NULL
essentially	NULL
as	NULL
described	NULL
by	NULL
Hansel	NULL
et	NULL
al	NULL
.	NULL
``	NULL

''	NULL
This	NULL
isolation	NULL
procedure	NULL
makes	NULL
use	NULL
of	NULL
the	NULL
fact	NULL
that	NULL
,	NULL
in	NULL
marked	NULL
contrast	NULL
to	NULL
neutrophils	NULL
,	NULL
eosinophils	NULL
lack	NULL
the	NULL
epitope	NULL
on	NULL
FoyR	NULL
HP®	NULL
recognized	NULL
by	NULL
the	NULL
MoAb	NULL
CLB-FcR-gran	NULL
1	NULL
.	NULL
``	NULL

As	NULL
a	NULL
result	NULL
,	NULL
highly	NULL
purified	NULL
eosinophils	NULL
can	NULL
be	NULL
isolated	NULL
by	NULL
removing	NULL
neutrophils	NULL
coated	NULL
with	NULL
FcR-gran-1	NULL
with	NULL
immunomagnetic	NULL
beads	NULL
.	NULL

In	NULL
short	NULL
,	NULL
neutrophils	NULL
were	NULL
coated	NULL
with	NULL
a	NULL
CD16	NULL
MoAb	NULL
(	NULL
CLB	NULL
FcR-gran	NULL
1	NULL
;	NULL
2	NULL
ug/10	NULL
'	NULL
cells/mL	NULL
)	NULL
for	NULL
20	NULL
minutes	NULL
at	NULL
4°C	NULL
.	NULL

Hereafter	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
and	NULL
subsequently	NULL
coincubated	NULL
head	NULL
over	NULL
head	NULL
with	NULL
dynabeads	NULL
coated	NULL
with	NULL
sheep	NULL
antimouse	NULL
antibodies	NULL
at	NULL
a	NULL
ratio	NULL
of	NULL
1:2	NULL
(	NULL
cells	NULL
:	NULL
beads	NULL
)	NULL
for	NULL
20	NULL
minutes	NULL
at	NULL
4°C	NULL
.	NULL

Neutrophils	NULL
were	NULL
subsequently	NULL
removed	NULL
by	NULL
a	NULL
magnetic	NULL
particle	NULL
concentrator	NULL
Dynal	NULL
)	NULL
.	NULL

Eosinophil	NULL
purity	NULL
was	NULL
always	NULL
greater	NULL
than	NULL
95	NULL
%	NULL
,	NULL
with	NULL
a	NULL
viability	NULL
of	NULL
more	NULL
than	NULL
98	NULL
%	NULL
as	NULL
judged	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
.	NULL

Immunoprecipitation	NULL
and	NULL
Western	NULL
blotting	NULL
.	NULL

-	NULL
After	NULL
incubation	NULL
with	NULL
IL-5	NULL
,	NULL
eosinophils	NULL
were	NULL
incubated	NULL
with	NULL
lysis	NULL
buffer	NULL
(	NULL
3	NULL
%	NULL
NP40	NULL
,	NULL
20	NULL
mmol/L	NULL
Tris/HCl	NULL
,	NULL
100	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
10	NULL
mmol/L	NULL
Na	NULL
,	NULL
P	NULL
;	NULL
,0	NULL
;	NULL
,	NULL
2	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
50	NULL
mmol/L	NULL
NaF	NULL
,	NULL
10	NULL
pg/mL	NULL
aprotinin	NULL
and	NULL
leupeptin	NULL
,	NULL
1	NULL
mmol/L	NULL
phenylmethylsulfony	NULL
]	NULL
fluoride	NULL
[	NULL
PMSF	NULL
]	NULL
,	NULL
and	NULL
1	NULL
mmol/L	NULL
Na	NULL
;	NULL
VO	NULL
,	NULL
,	NULL
pH	NULL
8.0	NULL
)	NULL
for	NULL
30	NULL
minutes	NULL
on	NULL
ice	NULL
.	NULL

The	NULL
lysate	NULL
was	NULL
centrifuged	NULL
(	NULL
10	NULL
minutes	NULL
at	NULL
1,000	NULL
g	NULL
at	NULL
4°C	NULL
)	NULL
to	NULL
remove	NULL
nuclei	NULL
and	NULL
cellular	NULL
debris	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
incubated	NULL
head	NULL
over	NULL
head	NULL
with	NULL
anti-JAK2	NULL
polyclonal	NULL
rabbit	NULL
antiserum	NULL
(	NULL
1.5	NULL
4L/2	NULL
to	NULL
4	NULL
X	NULL
10°	NULL
cell	NULL
equivalents	NULL
)	NULL
for	NULL
1	NULL
hour	NULL
at	NULL
4°C	NULL
before	NULL
protein-G	NULL
sepharose	NULL
was	NULL
added	NULL
for	NULL
an	NULL
overnight	NULL
incubation	NULL
at	NULL
4°C	NULL
.	NULL

Subsequently	NULL
,	NULL
the	NULL
protein-G	NULL
sepharose	NULL
was	NULL
washed	NULL
six	NULL
times	NULL
with	NULL
lysis	NULL
buffer	NULL
,	NULL
two	NULL
times	NULL
with	NULL
HEPES	NULL
buffer	NULL
containing	NULL
1	NULL
mmol/L	NULL
Na	NULL
;	NULL
VO	NULL
,	NULL
,	NULL
and	NULL
suspended	NULL
in	NULL
sample	NULL
buffer	NULL
(	NULL
4	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
[	NULL
SDS	NULL
]	NULL
,	NULL
4	NULL
%	NULL
A-mercaptoethanol	NULL
,	NULL
and	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
pH	NULL
6.8	NULL
)	NULL
.	NULL

Samples	NULL
were	NULL
run	NULL
on	NULL
a	NULL
7.5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
,	NULL
transferred	NULL
to	NULL
a	NULL
nitrocellulose	NULL
membrane	NULL
(	NULL
0.45	NULL
um	NULL
)	NULL
,	NULL
and	NULL
blotted	NULL
with	NULL
an	NULL
antiphosphotyrosine	NULL
(	NULL
anti-PTyr	NULL
)	NULL
MoAb	NULL
(	NULL
4G10	NULL
)	NULL
as	NULL
primary	NULL
antibody	NULL
and	NULL
peroxidase-conjugated	NULL
goat-antimouse	NULL
secondary	NULL
antibody	NULL
(	NULL
1:4,000	NULL
)	NULL
as	NULL
described	NULL
before	NULL
.	NULL
``	NULL

Immunoprecipitated	NULL
proteins	NULL
were	NULL
visualized	NULL
with	NULL
enhanced	NULL
chemiluminescence	NULL
(	NULL
ECL	NULL
;	NULL
Amers-ham	NULL
,	NULL
Buckinghamshire	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

Preparation	NULL
of	NULL
nuclear	NULL
extracts	NULL
.	NULL

-	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
before	NULL
with	NULL
a	NULL
few	NULL
modifications	NULL
.	NULL
``	NULL

In	NULL
short	NULL
,	NULL
eosinophils	NULL
(	NULL
>	NULL
5	NULL
x	NULL
10°	NULL
cells/extraction	NULL
)	NULL
were	NULL
suspended	NULL
in	NULL
400	NULL
gL	NULL
hypotonic	NULL
buffer	NULL
(	NULL
10	NULL
mmol/L	NULL
HEPES-KOH	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
1.5	NULL
mmol/L	NULL
MgCl	NULL
,	NULL
,	NULL
10	NULL
mmol/L	NULL
KCI	NULL
,	NULL
0.5	NULL
mmol/L	NULL
DTT	NULL
,	NULL
0.2	NULL
mmol/L	NULL
PMSF	NULL
,	NULL
10	NULL
pg/mL	NULL
aprotinin	NULL
,	NULL
and	NULL
1	NULL
mmol/L	NULL
Na	NULL
;	NULL
VO	NULL
,	NULL
)	NULL
and	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
minutes	NULL
.	NULL

Swollen	NULL
cells	NULL
and	NULL
nuclei	NULL
were	NULL
pelleted	NULL
and	NULL
subsequently	NULL
incubated	NULL
1443	NULL
on	NULL
ice	NULL
for	NULL
20	NULL
minutes	NULL
in	NULL
50	NULL
uL	NULL
hypertonic	NULL
buffer	NULL
(	NULL
20	NULL
mmol/L	NULL
HEPES-KOH	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
1.5	NULL
mmol/L	NULL
MgCl	NULL
,	NULL
,	NULL
420	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
0.2	NULL
mmoI/L	NULL
EDTA	NULL
,	NULL
0.5	NULL
mmol/L	NULL
DTT	NULL
,	NULL
0.2	NULL
mmol/L	NULL
PMSF	NULL
,	NULL
10	NULL
ug/mL	NULL
aprotinin	NULL
,	NULL
and	NULL
1	NULL
mmol/L	NULL
Na	NULL
;	NULL
VO	NULL
,	NULL
)	NULL
.	NULL

Hereafter	NULL
,	NULL
supernatants	NULL
were	NULL
col-lected	NULL
,	NULL
frozen	NULL
immediately	NULL
in	NULL
liquid	NULL
nitrogen	NULL
,	NULL
and	NULL
stored	NULL
at	NULL
-80°C	NULL
until	NULL
use	NULL
.	NULL

Electromobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

-	NULL
Nuclear	NULL
extracts	NULL
(	NULL
5	NULL
ug	NULL
pro-tein	NULL
)	NULL
were	NULL
incubated	NULL
(	NULL
20	NULL
wL	NULL
final	NULL
volume	NULL
)	NULL
for	NULL
30	NULL
minutes	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
10	NULL
mmol/L	NULL
HEPES	NULL
,	NULL
pH	NULL
7.8	NULL
,	NULL
50	NULL
mmol/L	NULL
KCI	NULL
,	NULL
5	NULL
mmol/	NULL
L	NULL
MgC	NULL
]	NULL
;	NULL
,	NULL
1	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
(	NULL
wt/vol	NULL
)	NULL
,	NULL
5	NULL
mmol/L	NULL
DTT	NULL
,	NULL
2	NULL
ug	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
and	NULL
20	NULL
ug	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
BSA	NULL
)	NULL
with	NULL
0.1	NULL
to	NULL
1	NULL
ng	NULL
of	NULL
a	NULL
P-labeled	NULL
oligonucleotide	NULL
(	NULL
5'-agcttaggTTTCCGG-GAAAgcac-3	NULL
'	NULL
)	NULL
that	NULL
is	NULL
a	NULL
previously	NULL
described	NULL
palindromic	NULL
IL-6/IFN-y	NULL
response	NULL
element	NULL
from	NULL
the	NULL
ICAM-1	NULL
promotor	NULL
(	NULL
ICAM-1	NULL
pIRE	NULL
)	NULL
.	NULL
``	NULL

Samples	NULL
were	NULL
loaded	NULL
on	NULL
a	NULL
5	NULL
%	NULL
nondenaturating	NULL
polyacrylamide	NULL
gel	NULL
,	NULL
run	NULL
for	NULL
3	NULL
hours	NULL
at	NULL
150	NULL
V	NULL
,	NULL
fixed	NULL
in	NULL
10	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
methanol	NULL
and	NULL
10	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
acetic	NULL
acid	NULL
,	NULL
vacuum	NULL
dried	NULL
,	NULL
and	NULL
exposed	NULL
to	NULL
Fuji	NULL
RX	NULL
film	NULL
(	NULL
Fuji	NULL
Photo	NULL
Film	NULL
Co	NULL
Ltd	NULL
,	NULL
Japan	NULL
)	NULL
at	NULL
-70°C	NULL
for	NULL
1	NULL
to	NULL
2	NULL
days	NULL
.	NULL

For	NULL
supershift	NULL
analysis	NULL
,	NULL
nuclear	NULL
extracts	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
were	NULL
incubated	NULL
for	NULL
1	NULL
hour	NULL
on	NULL
ice	NULL
with	NULL
1	NULL
ug	NULL
anti-PTyr	NULL
MoAb	NULL
(	NULL
4G10	NULL
)	NULL
or	NULL
the	NULL
antibodies	NULL
directed	NULL
against	NULL
the	NULL
Stat	NULL
proteins	NULL
.	NULL

For	NULL
competition	NULL
analysis	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
preincubated	NULL
for	NULL
10	NULL
minutes	NULL
with	NULL
50-	NULL
or	NULL
100-fold	NULL
excess	NULL
unlabeled	NULL
wild-type	NULL
oligonucleotide	NULL
or	NULL
mutant	NULL
oligonucleotide	NULL
(	NULL
5	NULL
'	NULL
-aggegegaggTTAGCGGTCAAgcagcacege-3	NULL
'	NULL
)	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
P-labeled	NULL
ICAM-1	NULL
pIRE	NULL
.	NULL

RESULTS	NULL
AND	NULL
DISCUSSION	NULL
Effect	NULL
of	NULL
IL-5	NULL
on	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK2	NULL
.	NULL

Although	NULL
it	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
IL-5	NULL
clearly	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
multiple	NULL
cellular	NULL
substrates	NULL
,	NULL
``	NULL
it	NULL
is	NULL
currently	NULL
unknown	NULL
which	NULL
kinase	NULL
(	NULL
s	NULL
)	NULL
are	NULL
involved	NULL
in	NULL
IL-5	NULL
signaling	NULL
.	NULL

We	NULL
focused	NULL
our	NULL
attention	NULL
on	NULL
JAK	NULL
kinases	NULL
,	NULL
because	NULL
these	NULL
tyrosine	NULL
kinases	NULL
are	NULL
activated	NULL
by	NULL
several	NULL
cytokines	NULL
,	NULL
including	NULL
IL-3	NULL
and	NULL
GM-CSF	NULL
.	NULL
``	NULL

Activation	NULL
of	NULL
JAK	NULL
kinases	NULL
is	NULL
associated	NULL
with	NULL
phosphorylation	NULL
of	NULL
these	NULL
kinases	NULL
on	NULL
tyrosine	NULL
resi-dues	NULL
,	NULL
probably	NULL
because	NULL
of	NULL
autophosphorylation	NULL
.	NULL
``	NULL

''	NULL
As	NULL
shown	NULL
in	NULL
Fig	NULL
1	NULL
,	NULL
IL-5	NULL
induced	NULL
a	NULL
rapid	NULL
and	NULL
transient	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK2	NULL
as	NULL
assessed	NULL
by	NULL
JAK2	NULL
immunoprecipita-tion	NULL
,	NULL
followed	NULL
by	NULL
Western	NULL
blotting	NULL
with	NULL
an	NULL
anti-PTyr	NULL
MoAb	NULL
(	NULL
4G10	NULL
)	NULL
.	NULL

TYK2	NULL
is	NULL
not	NULL
phosphorylated	NULL
on	NULL
tyrosine	NULL
upon	NULL
IL-5	NULL
treatment	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
at	NULL
10	NULL
minutes	NULL
,	NULL
a	NULL
second	NULL
protein	NULL
(	NULL
+155	NULL
kD	NULL
)	NULL
phosphorylated	NULL
on	NULL
tyrosine	NULL
consistently	NULL
appeared	NULL
that	NULL
coimmunoprecipitated	NULL
with	NULL
JAK2	NULL
.	NULL

Time	NULL
course	NULL
of	NULL
IL-5-induced	NULL
DNA-binding	NULL
complexes	NULL
with	NULL
the	NULL
ICAM-1	NULL
pIRE	NULL
.	NULL

-	NULL
Activation	NULL
of	NULL
JAK	NULL
kinases	NULL
is	NULL
important	NULL
for	NULL
the	NULL
subsequent	NULL
activation	NULL
of	NULL
Stat	NULL
proteins	NULL
.	NULL
``	NULL

This	NULL
finding	NULL
prompted	NULL
us	NULL
to	NULL
study	NULL
whether	NULL
IL-5	NULL
could	NULL
induce	NULL
DNA-binding	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
gamma	NULL
activated	NULL
site	NULL
(	NULL
GAS	NULL
)	NULL
-like	NULL
element	NULL
of	NULL
the	NULL
ICAM-1	NULL
promotor	NULL
,	NULL
ICAM-1	NULL
pIRE	NULL
(	NULL
5'-agettaggTTTCCGGGAAAgcac-3	NULL
'	NULL
)	NULL
,	NULL
that	NULL
we	NULL
have	NULL
previously	NULL
shown	NULL
to	NULL
bind	NULL
Stat	NULL
proteins	NULL
.	NULL
``	NULL

ICAM-1	NULL
can	NULL
be	NULL
induced	NULL
on	NULL
human	NULL
eosinophils	NULL
``	NULL
and	NULL
is	NULL
an	NULL
important	NULL
adhesion	NULL
molecule	NULL
in	NULL
allergic	NULL
inflammation	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
ICAM-1	NULL
pIRE	NULL
was	NULL
considered	NULL
an	NULL
appropriate	NULL
model	NULL
system	NULL
to	NULL
study	NULL
IL-5	NULL
signaling	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
eosinophils	NULL
,	NULL
which	NULL
were	NULL
treated	NULL
with	NULL
IL-5	NULL
(	NULL
5	NULL
x	NULL
10~	NULL
'	NULL
``	NULL
mol/L	NULL
)	NULL
.	NULL

These	NULL
extracts	NULL
were	NULL
used	NULL
for	NULL
an	NULL
EMSA	NULL
with	NULL
the	NULL
[	NULL
``	NULL
P	NULL
]	NULL
-ICAM-1	NULL
pIRE	NULL
.	NULL

IL-5	NULL
induced	NULL
at	NULL
least	NULL
two	NULL
DNA-binding	NULL
complexes	NULL
,	NULL
which	NULL
are	NULL
indicated	NULL
as	NULL
cl	NULL
and	NULL
c2	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
.	NULL

The	NULL
appearance	NULL
of	NULL
the	NULL
DNA	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1444	NULL
IL-5	NULL
(	NULL
min	NULL
)	NULL
reprobed	NULL
with	NULL
anti-	NULL
JAK	NULL
2	NULL
Fig	NULL
1	NULL
.	NULL

_	NULL
IL-5	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK2	NULL
.	NULL

Human	NULL
eosinophils	NULL
(	NULL
10	NULL
x	NULL
10°	NULL
cells/mL	NULL
)	NULL
were	NULL
treated	NULL
with	NULL
buffer	NULL
(	NULL
C	NULL
)	NULL
or	NULL
IL-5	NULL
(	NULL
5	NULL
x	NULL
10~	NULL
'	NULL
``	NULL
mol/L	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
at	NULL
37°C	NULL
.	NULL

Subsequently	NULL
,	NULL
JAK2	NULL
was	NULL
immunoprecipitated	NULL
and	NULL
used	NULL
for	NULL
Western	NULL
blot	NULL
with	NULL
an	NULL
anti-PTyr	NULL
MoAb	NULL
(	NULL
4G10	NULL
)	NULL
followed	NULL
by	NULL
ECL	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

Blots	NULL
were	NULL
reprobed	NULL
with	NULL
the	NULL
JAK2	NULL
antiserum	NULL
to	NULL
check	NULL
for	NULL
immunoprecipitation	NULL
efficiency	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
position	NULL
of	NULL
JAK2	NULL
(	NULL
130	NULL
kD	NULL
)	NULL
is	NULL
indicated	NULL
.	NULL

The	NULL
figure	NULL
is	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

binding	NULL
complexes	NULL
was	NULL
optimal	NULL
after	NULL
15	NULL
minutes	NULL
and	NULL
decreased	NULL
to	NULL
basal	NULL
levels	NULL
after	NULL
2.5	NULL
hours	NULL
.	NULL

The	NULL
c1	NULL
and	NULL
c2	NULL
complexes	NULL
were	NULL
specific	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
3	NULL
.	NULL

Formation	NULL
of	NULL
the	NULL
c1	NULL
and	NULL
c2	NULL
complexes	NULL
was	NULL
completely	NULL
inhibited	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
excess	NULL
(	NULL
50-	NULL
or	NULL
100-fold	NULL
)	NULL
unlabeled	NULL
wild-type	NULL
oligonucleotide	NULL
.	NULL

Excess	NULL
mutant	NULL
oligonucleotide	NULL
(	NULL
5S'-aggegegaggTTAGCGGTCAAgcagcacege-3	NULL
'	NULL
)	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
c1	NULL
and	NULL
c2	NULL
complex	NULL
formation	NULL
with	NULL
the	NULL
P-labeled	NULL
wild-type	NULL
probe	NULL
,	NULL
even	NULL
at	NULL
100-fold	NULL
excess	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

Supershift	NULL
analysis	NULL
of	NULL
the	NULL
IL-5-	NULL
and	NULL
IFN-y-induced	NULL
DNA-binding	NULL
factors	NULL
.	NULL

In	NULL
marked	NULL
contrast	NULL
to	NULL
IL-5	NULL
,	NULL
which	NULL
induced	NULL
at	NULL
least	NULL
two	NULL
ICAM-1	NULL
pIRE	NULL
binding	NULL
complexes	NULL
,	NULL
IFN-y	NULL
induced	NULL
a	NULL
single	NULL
DNA-binding	NULL
complex	NULL
(	NULL
Fig	NULL
4	NULL
)	NULL
.	NULL

To	NULL
characterize	NULL
the	NULL
proteins	NULL
binding	NULL
to	NULL
the	NULL
ICAM-1	NULL
pIRE	NULL
,	NULL
we	NULL
performed	NULL
supershift	NULL
analysis	NULL
of	NULL
the	NULL
ICAM-1	NULL
pIRE/protein	NULL
complexes	NULL
with	NULL
antibodies	NULL
raised	NULL
against	NULL
Stat	NULL
proteins	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
4	NULL
,	NULL
the	NULL
complex	NULL
that	NULL
was	NULL
induced	NULL
by	NULL
IFN-y	NULL
was	NULL
clearly	NULL
supershifted	NULL
by	NULL
an	NULL
antiserum	NULL
specifically	NULL
directed	NULL
against	NULL
Statlae	NULL
,	NULL
indicating	NULL
that	NULL
this	NULL
ICAM-1	NULL
pIRE/protein	NULL
complex	NULL
contained	NULL
Statle	NULL
.	NULL

An	NULL
MoAb	NULL
directed	NULL
against	NULL
an	NULL
epitope	NULL
that	NULL
is	NULL
present	NULL
in	NULL
Statla	NULL
and	NULL
Stat1/3	NULL
also	NULL
supershifted	NULL
this	NULL
complex	NULL
(	NULL
Fig	NULL
4	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
in	NULL
agreement	NULL
with	NULL
those	NULL
of	NULL
other	NULL
studies	NULL
,	NULL
demonstrating	NULL
that	NULL
IFN-y	NULL
induces	NULL
a	NULL
Statle	NULL
homodimer	NULL
.	NULL
``	NULL

When	NULL
the	NULL
same	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
ICAM-1	NULL
pIRE/protein	NULL
complexes	NULL
induced	NULL
by	NULL
IL-5	NULL
(	NULL
30	NULL
minutes	NULL
of	NULL
treatment	NULL
)	NULL
,	NULL
the	NULL
faster	NULL
migrating	NULL
complex	NULL
(	NULL
c2	NULL
)	NULL
of	NULL
the	NULL
doublet	NULL
was	NULL
supershifted	NULL
with	NULL
the	NULL
MoAb	NULL
against	NULL
Statla/	NULL
$	NULL
3	NULL
,	NULL
although	NULL
the	NULL
signal	NULL
intensity	NULL
of	NULL
the	NULL
complex	NULL
decreased	NULL
.	NULL

Inhibition	NULL
of	NULL
VAN	NULL
DER	NULL
BRUGGEN	NULL
ET	NULL
AL	NULL
the	NULL
IFN-y-induced	NULL
DNA-binding	NULL
complex	NULL
by	NULL
this	NULL
antibody	NULL
can	NULL
not	NULL
be	NULL
observed	NULL
in	NULL
this	NULL
figure	NULL
because	NULL
of	NULL
overexposure	NULL
of	NULL
the	NULL
film	NULL
.	NULL

At	NULL
much	NULL
shorter	NULL
exposure	NULL
times	NULL
,	NULL
the	NULL
IFN-y-induced	NULL
DNA-binding	NULL
complex	NULL
and	NULL
the	NULL
IL-5-induced	NULL
c2	NULL
complex	NULL
were	NULL
similarly	NULL
inhibited	NULL
by	NULL
the	NULL
anti-Statl	NULL
«	NULL
/3	NULL
MoAb	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
Statla-specific	NULL
antiserum	NULL
supershifted	NULL
the	NULL
c2	NULL
complex	NULL
induced	NULL
by	NULL
IL-5	NULL
to	NULL
the	NULL
top	NULL
of	NULL
the	NULL
lane	NULL
,	NULL
similar	NULL
to	NULL
the	NULL
supershift	NULL
of	NULL
the	NULL
IFN-y-induced	NULL
DNA-binding	NULL
complex	NULL
(	NULL
Fig	NULL
4	NULL
)	NULL
.	NULL

Isotype	NULL
antibody	NULL
controls	NULL
for	NULL
anti-Statla/	NULL
B	NULL
MoAb	NULL
(	NULL
mouse	NULL
IgG1	NULL
)	NULL
and	NULL
the	NULL
Statlae-specific	NULL
antiserum	NULL
(	NULL
nonimmune	NULL
rabbit	NULL
antiserum	NULL
)	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
both	NULL
IL-5-induced	NULL
DNA-binding	NULL
complexes	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
Statla	NULL
is	NULL
induced	NULL
by	NULL
IL-5	NULL
in	NULL
human	NULL
eosinophils	NULL
.	NULL

The	NULL
c2	NULL
complex	NULL
comigrates	NULL
with	NULL
the	NULL
IFN-y-induced	NULL
time	NULL
(	NULL
min	NULL
)	NULL
15	NULL
30	NULL
60	NULL
150	NULL
j	NULL
l	NULL
i	NULL
-	NULL
PMF	NULL
!	NULL

1	NULL
2	NULL
8	NULL
4	NULL
5	NULL
6	NULL
Fig	NULL
2	NULL
.	NULL

IL-5	NULL
treatment	NULL
of	NULL
human	NULL
eosinophils	NULL
leads	NULL
to	NULL
transient	NULL
induction	NULL
of	NULL
ICAM-1	NULL
pIRE	NULL
binding	NULL
activity	NULL
.	NULL

Human	NULL
eosinophils	NULL
were	NULL
isolated	NULL
from	NULL
the	NULL
peripheral	NULL
blood	NULL
of	NULL
healthy	NULL
volunteers	NULL
and	NULL
incubated	NULL
(	NULL
10	NULL
x	NULL
10°	NULL
cells/mL	NULL
)	NULL
with	NULL
buffer	NULL
(	NULL
control	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
IL-5	NULL
(	NULL
5	NULL
x	NULL
10~	NULL
``	NULL
°	NULL
mol/L	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
at	NULL
37°C	NULL
(	NULL
lanes	NULL
2	NULL
through	NULL
6	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
.	NULL

Nuclear	NULL
extracts	NULL
(	NULL
5	NULL
ug/	NULL
lane	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
P-labeled	NULL
oligonucleotide	NULL
(	NULL
5'-agcettagg-TTTCCGGGAAAgcac-3	NULL
'	NULL
)	NULL
encoding	NULL
a	NULL
palindromic	NULL
IFN/IL-6	NULL
response	NULL
element	NULL
from	NULL
the	NULL
ICAM-1	NULL
promotor	NULL
(	NULL
pIRE	NULL
)	NULL
.	NULL

IL-5	NULL
induced	NULL
two	NULL
clear	NULL
DNA	NULL
binding	NULL
complexes	NULL
designated	NULL
as	NULL
c1	NULL
and	NULL
c2	NULL
.	NULL

The	NULL
data	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
additional	NULL
experiments	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

IL-5	NULL
SIGNALING	NULL
IN	NULL
HUMAN	NULL
EOSINOPHILS	NULL
competitor	NULL
x	NULL
5	NULL
S	NULL
wild	NULL
type	NULL
Io	NULL
woo	NULL
m-	NULL
od	NULL
1	NULL
X	NULL
x	NULL
o	NULL
0	NULL
o	NULL
mutant	NULL
1	NULL
1	NULL
10	NULL
O°	NULL
&	NULL
®	NULL
tle	NULL
4	NULL
®	NULL
4	NULL
5	NULL
1°	NULL
208	NULL
Fig	NULL
3	NULL
.	NULL

Specificity	NULL
of	NULL
the	NULL
IL-5-induced	NULL
ICAM-1	NULL
pIRE	NULL
binding	NULL
complexes	NULL
.	NULL

IL-5-induced	NULL
DNA-binding	NULL
complexes	NULL
are	NULL
shown	NULL
in	NULL
lane	NULL
1	NULL
and	NULL
are	NULL
designated	NULL
c1	NULL
and	NULL
c2	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
50-	NULL
or	NULL
100-fold	NULL
excess	NULL
unlabeled	NULL
wild-type	NULL
oligonucleotide	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
or	NULL
mutant	NULL
oligonucleotide	NULL
(	NULL
5'-aggegegaggTTAGCGGTC-AAgcagcacegc-3	NULL
'	NULL
;	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
10	NULL
minutes	NULL
before	NULL
incubation	NULL
with	NULL
the	NULL
P-labeled	NULL
ICAM-1	NULL
pIRE	NULL
.	NULL

The	NULL
data	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
additional	NULL
experiments	NULL
.	NULL

Statla	NULL
homodimer	NULL
,	NULL
further	NULL
suggesting	NULL
that	NULL
complex	NULL
c2	NULL
contains	NULL
a	NULL
Statle	NULL
homodimer	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
slower	NULL
migrating	NULL
complex	NULL
(	NULL
cl	NULL
)	NULL
was	NULL
partially	NULL
inhibited	NULL
by	NULL
both	NULL
antibodies	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
complex	NULL
contains	NULL
a	NULL
Statla-related	NULL
protein	NULL
or	NULL
Statla	NULL
as	NULL
part	NULL
of	NULL
a	NULL
heterodimer	NULL
.	NULL

Possibly	NULL
,	NULL
the	NULL
anti-Statle	NULL
and	NULL
-Statla/	NULL
#	NULL
$	NULL
MoAbs	NULL
recognize	NULL
an	NULL
epitope	NULL
that	NULL
is	NULL
masked	NULL
in	NULL
a	NULL
putative	NULL
heterodimer	NULL
complex	NULL
,	NULL
explaining	NULL
the	NULL
partial	NULL
,	NULL
rather	NULL
than	NULL
total	NULL
,	NULL
inhibition	NULL
of	NULL
the	NULL
cl	NULL
complex	NULL
.	NULL

We	NULL
next	NULL
addressed	NULL
the	NULL
question	NULL
of	NULL
whether	NULL
phosphorylation	NULL
of	NULL
tyrosine	NULL
residues	NULL
is	NULL
important	NULL
for	NULL
the	NULL
IL-5-induced	NULL
proteins	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
ICAM-1	NULL
pIRE	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
4	NULL
,	NULL
preincubation	NULL
of	NULL
an	NULL
MoAb	NULL
(	NULL
4G10	NULL
)	NULL
directed	NULL
against	NULL
PTyr	NULL
inhibits	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
c1/c2	NULL
complexes	NULL
,	NULL
suggesting	NULL
the	NULL
importance	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
for	NULL
DNA	NULL
binding	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
found	NULL
with	NULL
another	NULL
anti-PTyr	NULL
MoAb	NULL
,	NULL
PY20	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Others	NULL
have	NULL
shown	NULL
that	NULL
phosphorylation	NULL
of	NULL
a	NULL
single	NULL
tyrosine	NULL
residue	NULL
(	NULL
Tyr'®	NULL
'	NULL
)	NULL
in	NULL
Statlae	NULL
is	NULL
neces-	NULL
1445	NULL
sary	NULL
for	NULL
nuclear	NULL
translocation	NULL
and	NULL
DNA-binding	NULL
.	NULL
``	NULL

''	NULL
When	NULL
the	NULL
MoAb	NULL
was	NULL
saturated	NULL
with	NULL
soluble	NULL
phosphotyrosine	NULL
,	NULL
thereby	NULL
inhibiting	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
MoAb	NULL
,	NULL
the	NULL
inhibition	NULL
of	NULL
the	NULL
formation	NULL
of	NULL
ICAM-1	NULL
pIRE/Stat	NULL
complexes	NULL
was	NULL
eliminated	NULL
.	NULL

Effect	NULL
of	NULL
GM-CSF	NULL
and	NULL
IL-3	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
ICAM-1	NULL
pIRE/Stat	NULL
complexes	NULL
in	NULL
human	NULL
eosinophils	NULL
.	NULL

_	NULL
GM-CSF	NULL
(	NULL
10	NULL
°	NULL
IFN-y	NULL
IL-5	NULL
+	NULL
10	NULL
mM	NULL
PTyr	NULL
a	NULL
stat9	NULL
1	NULL
a	NULL
stat9	NULL
1/84	NULL
a	NULL
PTyr	NULL
a	NULL
stat9	NULL
1/84	NULL
a	NULL
PTyr	NULL
a	NULL
stat9	NULL
1	NULL
antibody	NULL
1	NULL
P91	NULL
P	NULL
i	NULL
:	NULL
%	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
Fig	NULL
4	NULL
.	NULL

IL-5-induced	NULL
ICAM-1	NULL
pIRE	NULL
binding	NULL
complexes	NULL
contain	NULL
Stat	NULL
proteins	NULL
phosphorylated	NULL
on	NULL
tyrosine	NULL
.	NULL

Eosinophils	NULL
were	NULL
treated	NULL
for	NULL
30	NULL
minutes	NULL
with	NULL
IL-5	NULL
(	NULL
5	NULL
x	NULL
10~	NULL
``	NULL
mol/L	NULL
)	NULL
or	NULL
IFN-y	NULL
(	NULL
500	NULL
U/mL	NULL
)	NULL
at	NULL
37°C	NULL
.	NULL

Hereafter	NULL
,	NULL
nuclear	NULL
extracts	NULL
(	NULL
5	NULL
g/lane	NULL
)	NULL
were	NULL
incubated	NULL
for	NULL
60	NULL
minutes	NULL
at	NULL
0°C	NULL
with	NULL
an	NULL
anti-Stat91	NULL
polyclonal	NULL
antiserum	NULL
(	NULL
Stati	NULL
,	NULL
1	NULL
mg	NULL
;	NULL
lanes	NULL
2	NULL
and	NULL
5	NULL
)	NULL
,	NULL
an	NULL
anti-Stat91/84	NULL
MoAb	NULL
(	NULL
Stat1ie/	NULL
$	NULL
B	NULL
,	NULL
1	NULL
ug	NULL
;	NULL
lanes	NULL
3	NULL
and	NULL
6	NULL
)	NULL
,	NULL
or	NULL
anti-PTyr	NULL
MoAb	NULL
(	NULL
2	NULL
pg	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
of	NULL
1	NULL
mmol/L	NULL
phosphotyrosine	NULL
.	NULL

IL-5-induced	NULL
complexes	NULL
are	NULL
designated	NULL
as	NULL
c1	NULL
and	NULL
c2	NULL
.	NULL

The	NULL
data	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
additional	NULL
experiments	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1446	NULL
IL-3	NULL
_	NULL
GM-CSF	NULL
bas	NULL
#	NULL
co	NULL
co	NULL
~	NULL
~	NULL
r=	NULL
v-	NULL
Lad	NULL
r-oa	NULL
-a	NULL
oa	NULL
-	NULL
a	NULL
hed	NULL
hed	NULL
LJ	NULL
Lad	NULL
s	NULL
-	NULL
a	NULL
a	NULL
a	NULL
bed	NULL
+	NULL
«	NULL
e	NULL
hed	NULL
©	NULL
-	NULL
a	NULL
©	NULL
3	NULL
antibody	NULL
1	NULL
u	NULL
us	NULL
1	NULL
u	NULL
5	NULL
-~	NULL
«	NULL
~	NULL
#	NULL
B	NULL
om	NULL
C1	NULL
»	NULL
C2	NULL
»	NULL
4	NULL
5	NULL
6	NULL
1	NULL
2	NULL
3	NULL
Fig	NULL
5	NULL
.	NULL

IL-3-	NULL
and	NULL
GM-CSF~induced	NULL
DNA-binding	NULL
complexes	NULL
contain	NULL
Stat	NULL
proteins	NULL
.	NULL

Human	NULL
eosinophils	NULL
were	NULL
incubated	NULL
for	NULL
30	NULL
minutes	NULL
with	NULL
IL-3	NULL
(	NULL
10~°	NULL
mol/L	NULL
)	NULL
or	NULL
GM-SF	NULL
(	NULL
10~°	NULL
mol/L	NULL
)	NULL
at	NULL
37°C	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
incubated	NULL
(	NULL
5	NULL
mg/lane	NULL
)	NULL
for	NULL
60	NULL
minutes	NULL
at	NULL
0°C	NULL
with	NULL
no	NULL
MoAb	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
4	NULL
)	NULL
,	NULL
MoAb	NULL
directed	NULL
against	NULL
Stat91/84	NULL
(	NULL
Statie/	NULL
B	NULL
,	NULL
1	NULL
ug	NULL
;	NULL
lanes	NULL
2	NULL
and	NULL
5	NULL
)	NULL
,	NULL
or	NULL
a	NULL
polyclonal	NULL
antiserum	NULL
directed	NULL
against	NULL
Stat91	NULL
(	NULL
Statia	NULL
,	NULL
1	NULL
ug	NULL
;	NULL
lanes	NULL
3	NULL
and	NULL
6	NULL
)	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
[	NULL
*P	NULL
]	NULL
-ICAM-1	NULL
pIRE	NULL
.	NULL

Two	NULL
clear	NULL
DNA	NULL
complexes	NULL
are	NULL
designated	NULL
as	NULL
c1	NULL
and	NULL
c2	NULL
.	NULL

The	NULL
data	NULL
are	NULL
representative	NULL
of	NULL
two	NULL
other	NULL
experiments	NULL
.	NULL

mol/L	NULL
)	NULL
and	NULL
IL-3	NULL
(	NULL
10	NULL
~*	NULL
mol/L	NULL
)	NULL
also	NULL
induced	NULL
at	NULL
least	NULL
two	NULL
DNA-binding	NULL
complexes	NULL
in	NULL
gelshift	NULL
assays	NULL
using	NULL
nuclear	NULL
extracts	NULL
of	NULL
human	NULL
eosinophils	NULL
and	NULL
the	NULL
P	NULL
ICAM-1	NULL
pIRE	NULL
(	NULL
see	NULL
Fig	NULL
5	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
relative	NULL
high	NULL
concentrations	NULL
(	NULL
10~°	NULL
mol/L	NULL
)	NULL
of	NULL
GM-CSF	NULL
were	NULL
needed	NULL
for	NULL
substantial	NULL
induction	NULL
of	NULL
the	NULL
two	NULL
DNA-binding	NULL
complexes	NULL
,	NULL
whereas	NULL
it	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
VAN	NULL
DER	NULL
BRUGGEN	NULL
ET	NULL
AL	NULL
GM-CSF	NULL
primes	NULL
eosinophil	NULL
function	NULL
at	NULL
picomolar	NULL
concentra-tions	NULL
.	NULL
``	NULL

Again	NULL
,	NULL
in	NULL
supershift	NULL
experiments	NULL
,	NULL
it	NULL
is	NULL
shown	NULL
that	NULL
the	NULL
faster	NULL
migrating	NULL
complex	NULL
c2	NULL
supershifted	NULL
with	NULL
the	NULL
antiserum	NULL
specific	NULL
for	NULL
Statla	NULL
and	NULL
the	NULL
MoAb	NULL
directed	NULL
against	NULL
the	NULL
epitope	NULL
found	NULL
in	NULL
both	NULL
Statle	NULL
and	NULL
Stat13	NULL
.	NULL

These	NULL
findings	NULL
indicate	NULL
that	NULL
IL-3	NULL
and	NULL
GM-CSF	NULL
can	NULL
induce	NULL
Statla	NULL
in	NULL
normal	NULL
human	NULL
eosinophils	NULL
.	NULL

The	NULL
upper	NULL
complex	NULL
c1	NULL
was	NULL
partially	NULL
inhibited	NULL
by	NULL
both	NULL
antibodies	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
complex	NULL
also	NULL
contains	NULL
a	NULL
Statla-related	NULL
protein	NULL
or	NULL
Statla	NULL
as	NULL
a	NULL
heterodimer	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
donor	NULL
variation	NULL
existed	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
signals	NULL
of	NULL
the	NULL
cl	NULL
and	NULL
,	NULL
especially	NULL
,	NULL
the	NULL
c2	NULL
complex	NULL
.	NULL

However	NULL
,	NULL
the	NULL
c1	NULL
and	NULL
c2	NULL
complexes	NULL
were	NULL
found	NULL
in	NULL
the	NULL
majority	NULL
of	NULL
the	NULL
experiments	NULL
and	NULL
the	NULL
c2	NULL
complex	NULL
was	NULL
always	NULL
supershifted	NULL
with	NULL
the	NULL
anti-Statla	NULL
and	NULL
anti-Statla	NULL
«	NULL
/	NULL
$	NULL
3	NULL
antibodies	NULL
.	NULL

In	NULL
marked	NULL
contrast	NULL
to	NULL
this	NULL
study	NULL
,	NULL
others	NULL
have	NULL
shown	NULL
that	NULL
,	NULL
in	NULL
monocytes	NULL
,	NULL
U937	NULL
cells	NULL
,	NULL
and	NULL
cells	NULL
,	NULL
IL-3	NULL
and	NULL
GM-CSF	NULL
induce	NULL
a	NULL
single	NULL
complex	NULL
that	NULL
is	NULL
neither	NULL
supershifted	NULL
nor	NULL
inhibited	NULL
by	NULL
anti-Statle	NULL
antibodies	NULL
but	NULL
is	NULL
able	NULL
to	NULL
bind	NULL
to	NULL
GAS	NULL
oligonucleotides	NULL
.	NULL

``	NULL
``	NULL
*	NULL
'	NULL
However	NULL
,	NULL
it	NULL
is	NULL
reported	NULL
that	NULL
IL-3	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Statla	NULL
,	NULL
although	NULL
signals	NULL
were	NULL
rather	NULL
low	NULL
.	NULL
``	NULL

It	NULL
was	NULL
found	NULL
that	NULL
IL-5	NULL
induced	NULL
a	NULL
DNA-binding	NULL
complex	NULL
in	NULL
human	NULL
basophils	NULL
;	NULL
however	NULL
,	NULL
no	NULL
supershift	NULL
experiments	NULL
were	NULL
performed	NULL
to	NULL
further	NULL
analyze	NULL
this	NULL
com-plex	NULL
.	NULL

*	NULL
'	NULL
The	NULL
reason	NULL
why	NULL
Statla	NULL
DNA-binding	NULL
activity	NULL
is	NULL
not	NULL
induced	NULL
by	NULL
IL-3	NULL
and	NULL
GM-CSF	NULL
in	NULL
the	NULL
aforementioned	NULL
studies	NULL
is	NULL
not	NULL
clear	NULL
,	NULL
but	NULL
might	NULL
reflect	NULL
a	NULL
difference	NULL
in	NULL
binding	NULL
affinity	NULL
and/or	NULL
specificity	NULL
of	NULL
Stat	NULL
proteins	NULL
for	NULL
the	NULL
oligonucleotides	NULL
used	NULL
in	NULL
those	NULL
studies	NULL
and	NULL
ours	NULL
,	NULL
ie	NULL
,	NULL
the	NULL
GAS	NULL
element	NULL
of	NULL
the	NULL
Ly6E	NULL
promotor	NULL
and	NULL
the	NULL
IFN-y	NULL
response	NULL
region	NULL
of	NULL
the	NULL
FeyRI	NULL
promotor	NULL
versus	NULL
the	NULL
ICAM-1	NULL
pIRE	NULL
.	NULL

``	NULL
``	NULL
*	NULL
'	NULL
Alternatively	NULL
,	NULL
the	NULL
different	NULL
cell	NULL
types	NULL
possibly	NULL
determine	NULL
the	NULL
pattern	NULL
of	NULL
Stat	NULL
proteins	NULL
(	NULL
and/or	NULL
other	NULL
transcription	NULL
factors	NULL
as	NULL
well	NULL
)	NULL
that	NULL
are	NULL
induced	NULL
by	NULL
IL-3	NULL
and	NULL
GM-CSF	NULL
.	NULL

IL-3	NULL
,	NULL
GM-CSF	NULL
,	NULL
and	NULL
IFN-y	NULL
induce	NULL
the	NULL
expression	NULL
of	NULL
several	NULL
molecules	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
of	NULL
eosinophils	NULL
,	NULL
such	NULL
as	NULL
the	NULL
IL-2	NULL
receptor	NULL
pSS	NULL
chain	NULL
,	NULL
CD4	NULL
,	NULL
and	NULL
ICAM-I	NULL
expression	NULL
is	NULL
markedly	NULL
induced	NULL
by	NULL
TNF-a	NULL
together	NULL
with	NULL
IFN-y	NULL
,	NULL
GM-CSF	NULL
,	NULL
IL-3	NULL
,	NULL
or	NULL
IL-5.5°	NULL
In	NULL
the	NULL
case	NULL
of	NULL
the	NULL
ICAM-1	NULL
gene	NULL
,	NULL
a	NULL
Stat-binding	NULL
element	NULL
has	NULL
been	NULL
identified	NULL
.	NULL
``	NULL

Characterization	NULL
of	NULL
other	NULL
genes	NULL
encoding	NULL
cell	NULL
surface	NULL
proteins	NULL
induced	NULL
by	NULL
IL-5	NULL
,	NULL
IL-3	NULL
,	NULL
GM-CSF	NULL
,	NULL
or	NULL
IFN-y	NULL
possibly	NULL
shows	NULL
Stat	NULL
binding	NULL
sequences	NULL
in	NULL
the	NULL
promotor	NULL
region	NULL
as	NULL
well	NULL
.	NULL

This	NULL
would	NULL
provide	NULL
a	NULL
molecular	NULL
basis	NULL
for	NULL
regulation	NULL
of	NULL
these	NULL
genes	NULL
upon	NULL
addition	NULL
of	NULL
these	NULL
cytokines	NULL
to	NULL
human	NULL
eosinophils	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
IL-5	NULL
signaling	NULL
in	NULL
human	NULL
eosinophils	NULL
involves	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK2	NULL
and	NULL
the	NULL
induction	NULL
of	NULL
DNA-binding	NULL
complexes	NULL
containing	NULL
Statla	NULL
and	NULL
,	NULL
possibly	NULL
,	NULL
a	NULL
Stat-related	NULL
factor	NULL
.	NULL

NOTE	NULL
ADDED	NULL
IN	NULL
PROOF	NULL
After	NULL
the	NULL
submission	NULL
of	NULL
this	NULL
manuscript	NULL
,	NULL
Sato	NULL
et	NULL
al	NULL
(	NULL
J	NULL
Exp	NULL
Med	NULL
180:2101	NULL
,	NULL
1994	NULL
)	NULL
reported	NULL
that	NULL
IL-5	NULL
induces	NULL
activation	NULL
of	NULL
JAK2	NULL
tyrosine	NULL
kinase	NULL
in	NULL
an	NULL
mIL-5-dependent	NULL
murine	NULL
early	NULL
B-cell	NULL
line	NULL
(	NULL
Y¥16	NULL
)	NULL
.	NULL

ACKNOWLEDGMENT	NULL
The	NULL
authors	NULL
thank	NULL
Dr	NULL
Rolf	NULL
P.	NULL
de	NULL
Groot	NULL
and	NULL
Dr	NULL
Arthur	NULL
J.	NULL
Verhoeven	NULL
for	NULL
critically	NULL
reading	NULL
the	NULL
manuscript	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Dr	NULL
C.	NULL
Schindler	NULL
and	NULL
Dr	NULL
F.	NULL
Horn	NULL
for	NULL
the	NULL
gift	NULL
of	NULL
Stat	NULL
antibodies	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

IL-5	NULL
SIGNALING	NULL
IN	NULL
HUMAN	NULL
EOSINOPHILS	NULL
REFERENCES	NULL
1	NULL
.	NULL

Gleich	NULL
GJ	NULL
:	NULL
The	NULL
eosinophil	NULL
and	NULL
bronchial	NULL
asthma	NULL
:	NULL
current	NULL
under-standing	NULL
.	NULL

J	NULL
Allergy	NULL
Clin	NULL
Immunol	NULL
85:422	NULL
,	NULL
1990	NULL
2	NULL
.	NULL

Rand	NULL
TH	NULL
,	NULL
Silberstein	NULL
DS	NULL
,	NULL
Kornfeld	NULL
H	NULL
,	NULL
Weller	NULL
PF	NULL
:	NULL
Human	NULL
eosinophils	NULL
express	NULL
functional	NULL
interleukin	NULL
2	NULL
receptors	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
88:825	NULL
,	NULL
1991	NULL
3	NULL
.	NULL

Warringa	NULL
RAJ	NULL
,	NULL
Koenderman	NULL
L	NULL
,	NULL
Kok	NULL
PTM	NULL
,	NULL
Kreukniet	NULL
J	NULL
,	NULL
Bruijnzeel	NULL
PLB	NULL
:	NULL
Modulation	NULL
and	NULL
induction	NULL
of	NULL
eosinophil	NULL
chemotaxis	NULL
by	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
and	NULL
interleukin-3	NULL
.	NULL

Blood	NULL
77:2694	NULL
,	NULL
1991	NULL
4.	NULL
van	NULL
der	NULL
Bruggen	NULL
T	NULL
,	NULL
Kok	NULL
PTM	NULL
,	NULL
Raaijmakers	NULL
JAM	NULL
,	NULL
Verhoeven	NULL
AJ	NULL
,	NULL
Kessels	NULL
RGC	NULL
,	NULL
Lammers	NULL
JWJ	NULL
,	NULL
Koenderman	NULL
L	NULL
:	NULL
Cytokine	NULL
priming	NULL
of	NULL
the	NULL
respiratory	NULL
burst	NULL
in	NULL
human	NULL
eosinophils	NULL
is	NULL
Ca	NULL
``	NULL
*	NULL
independent	NULL
and	NULL
accompanied	NULL
by	NULL
induction	NULL
of	NULL
tyrosine	NULL
kinase	NULL
activity	NULL
.	NULL

J	NULL
Leukoc	NULL
Biol	NULL
53:347	NULL
,	NULL
1993	NULL
5	NULL
.	NULL

Hansel	NULL
TT	NULL
,	NULL
de	NULL
Vries	NULL
UM	NULL
,	NULL
Carballido	NULL
JM	NULL
,	NULL
Braun	NULL
RK	NULL
,	NULL
Carbal-lido-Perrig	NULL
N	NULL
,	NULL
Rihs	NULL
S	NULL
,	NULL
Blaser	NULL
K	NULL
,	NULL
Walker	NULL
C	NULL
:	NULL
Induction	NULL
and	NULL
function	NULL
of	NULL
eosinophil	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
and	NULL
HLA-DR.	NULL
J	NULL
Immunol	NULL
149:2130	NULL
,	NULL
1992	NULL
6	NULL
.	NULL

Czech	NULL
W	NULL
,	NULL
Krutmann	NULL
J	NULL
,	NULL
Budnik	NULL
A	NULL
,	NULL
Schiopf	NULL
E	NULL
,	NULL
Kapp	NULL
A	NULL
:	NULL
Induction	NULL
of	NULL
intercellular	NULL
adhesion	NULL
molecule	NULL
1	NULL
(	NULL
ICAM-1	NULL
)	NULL
expression	NULL
in	NULL
normal	NULL
human	NULL
eosinophils	NULL
by	NULL
inflammatory	NULL
cytokines	NULL
.	NULL

J	NULL
Invest	NULL
Dermatol	NULL
100:417	NULL
,	NULL
1993	NULL
7	NULL
.	NULL

Dubois	NULL
GR	NULL
,	NULL
Bruijnzeel-Koomen	NULL
CAFM	NULL
,	NULL
Bruijnzeel	NULL
PLB	NULL
:	NULL
IL-4	NULL
induces	NULL
chemotaxis	NULL
of	NULL
blood	NULL
eosinophils	NULL
from	NULL
atopic	NULL
dermatitis	NULL
patients	NULL
,	NULL
but	NULL
not	NULL
from	NULL
normal	NULL
individuals	NULL
.	NULL

J	NULL
Invest	NULL
Dermatol	NULL
102:843	NULL
,	NULL
1994	NULL
8	NULL
.	NULL

Schweizer	NULL
RC	NULL
,	NULL
Welmers	NULL
BAC	NULL
,	NULL
Raaijmakers	NULL
JAM	NULL
,	NULL
Zanen	NULL
P	NULL
,	NULL
Lammers	NULL
JWJ	NULL
,	NULL
Koenderman	NULL
L	NULL
:	NULL
Rantes-	NULL
and	NULL
interleukin-8-induced	NULL
responses	NULL
in	NULL
normal	NULL
human	NULL
eosinophils	NULL
:	NULL
Effects	NULL
of	NULL
priming	NULL
with	NULL
interleukin-5	NULL
.	NULL

Blood	NULL
83:3697	NULL
,	NULL
1994	NULL
9	NULL
.	NULL

Campbell	NULL
HD	NULL
,	NULL
Tucker	NULL
WQJ	NULL
,	NULL
Hort	NULL
Y	NULL
,	NULL
Martinson	NULL
ME	NULL
,	NULL
Mayo	NULL
G	NULL
,	NULL
Clutterbuck	NULL
EJ	NULL
,	NULL
Sanderson	NULL
CJ	NULL
,	NULL
Young	NULL
IG	NULL
:	NULL
Molecular	NULL
cloning	NULL
,	NULL
nucleotide	NULL
sequence	NULL
,	NULL
and	NULL
expression	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
human	NULL
eosinophil	NULL
differentiation	NULL
factor	NULL
(	NULL
interleukin	NULL
5	NULL
)	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
84:6629	NULL
,	NULL
1987	NULL
10	NULL
.	NULL

Warringa	NULL
RAJ	NULL
,	NULL
Mengelers	NULL
HJJ	NULL
,	NULL
Kuijper	NULL
PHM	NULL
,	NULL
Raaijmakers	NULL
JAM	NULL
,	NULL
Bruijnzeel	NULL
PLB	NULL
,	NULL
Koenderman	NULL
L	NULL
:	NULL
In	NULL
vivo	NULL
priming	NULL
of	NULL
platelet-activating	NULL
factor-induced	NULL
eosinophil	NULL
chemotaxis	NULL
in	NULL
allergic	NULL
asthmatic	NULL
individuals	NULL
.	NULL

Blood	NULL
79:1836	NULL
,	NULL
1992	NULL
11	NULL
.	NULL

Warringa	NULL
RAJ	NULL
,	NULL
Mengelers	NULL
HJJ	NULL
,	NULL
Raaijmakers	NULL
JAM	NULL
,	NULL
Bruijnzeel	NULL
PLB	NULL
,	NULL
Koenderman	NULL
L	NULL
:	NULL
Up-regulation	NULL
of	NULL
formyl-peptide	NULL
and	NULL
interleu-kin-8	NULL
induced	NULL
eosinophil	NULL
chemotaxis	NULL
in	NULL
allergic	NULL
asthmatic	NULL
individuals	NULL
.	NULL

J	NULL
Allergy	NULL
Clin	NULL
Immunol	NULL
91:1198	NULL
,	NULL
1993	NULL
12	NULL
.	NULL

Mengelers	NULL
HJ	NULL
,	NULL
Maikoe	NULL
T	NULL
,	NULL
Brinkman	NULL
L	NULL
,	NULL
Hooibrink	NULL
B	NULL
,	NULL
Lammers	NULL
JWJ	NULL
,	NULL
Koenderman	NULL
L	NULL
:	NULL
Immunophenotyping	NULL
of	NULL
eosinophils	NULL
recovered	NULL
from	NULL
blood	NULL
and	NULL
BAL	NULL
of	NULL
allergic	NULL
asthmatics	NULL
.	NULL

Am	NULL
J	NULL
Respir	NULL
Crit	NULL
Care	NULL
Med	NULL
149:345	NULL
,	NULL
1994	NULL
13	NULL
.	NULL

Lopez	NULL
AF	NULL
,	NULL
Elliot	NULL
MJ	NULL
,	NULL
Woodcock	NULL
J	NULL
,	NULL
Vadas	NULL
MA	NULL
:	NULL
GM-CSF	NULL
,	NULL
IL-3	NULL
and	NULL
IL-5	NULL
:	NULL
Cross-competition	NULL
on	NULL
human	NULL
haemopoietic	NULL
cells	NULL
.	NULL

Immunol	NULL
Today	NULL
13:495	NULL
,	NULL
1993	NULL
14	NULL
.	NULL

Lopez	NULL
AF	NULL
,	NULL
Eglinton	NULL
JM	NULL
,	NULL
Gillis	NULL
D	NULL
,	NULL
Park	NULL
LS	NULL
,	NULL
Clark	NULL
SC	NULL
,	NULL
Vadas	NULL
MA	NULL
:	NULL
Reciprocal	NULL
inhibition	NULL
of	NULL
binding	NULL
between	NULL
interleukin	NULL
3	NULL
and	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
to	NULL
human	NULL
eosinophils	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
86:7022	NULL
,	NULL
1989	NULL
15	NULL
.	NULL

Ingley	NULL
E	NULL
,	NULL
Young	NULL
IG	NULL
:	NULL
Characterization	NULL
of	NULL
a	NULL
receptor	NULL
for	NULL
interleukin-5	NULL
on	NULL
human	NULL
eosinophils	NULL
and	NULL
the	NULL
myeloid	NULL
leukemia	NULL
line	NULL
HL-60	NULL
.	NULL

Blood	NULL
78:339	NULL
,	NULL
1991	NULL
16	NULL
.	NULL

Kishimoto	NULL
T	NULL
,	NULL
Taga	NULL
T	NULL
,	NULL
Akira	NULL
S	NULL
:	NULL
Cytokine	NULL
signal	NULL
transduction	NULL
.	NULL

Cell	NULL
76:253	NULL
,	NULL
1994	NULL
17	NULL
.	NULL

Miyajima	NULL
A	NULL
,	NULL
Mui	NULL
ALF	NULL
,	NULL
Ogorochi	NULL
T	NULL
,	NULL
Sakamaki	NULL
K	NULL
:	NULL
Receptors	NULL
for	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
,	NULL
interleukin-3	NULL
and	NULL
interleukin-5	NULL
.	NULL

Blood	NULL
8	NULL
$	NULL
2:1960	NULL
,	NULL
1993	NULL
1447	NULL
18	NULL
.	NULL

Duronio	NULL
V	NULL
,	NULL
Clark-Lewis	NULL
I	NULL
,	NULL
Federsppiel	NULL
B	NULL
,	NULL
Wieler	NULL
JS	NULL
,	NULL
Schrader	NULL
JW	NULL
:	NULL
Tyrosine	NULL
phosphorylation	NULL
of	NULL
receptor	NULL
#	NULL
subunits	NULL
and	NULL
common	NULL
substrates	NULL
in	NULL
response	NULL
to	NULL
interleukin-3	NULL
and	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
267:21856	NULL
,	NULL
1992	NULL
19	NULL
.	NULL

Cutler	NULL
RL	NULL
,	NULL
Liu	NULL
L	NULL
,	NULL
Damen	NULL
JE	NULL
,	NULL
Krystal	NULL
G	NULL
:	NULL
Multiple	NULL
cytokines	NULL
induce	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Shc	NULL
and	NULL
its	NULL
association	NULL
with	NULL
Grb2	NULL
in	NULL
hemopoietic	NULL
cells	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
268:21463	NULL
,	NULL
1993	NULL
20	NULL
.	NULL

Satoh	NULL
T	NULL
,	NULL
Nakafuku	NULL
M	NULL
,	NULL
Miyajima	NULL
A	NULL
,	NULL
Kaziro	NULL
Y	NULL
:	NULL
Involvement	NULL
of	NULL
ras	NULL
p21	NULL
protein	NULL
in	NULL
signal-transduction	NULL
pathways	NULL
from	NULL
interleukin	NULL
2	NULL
,	NULL
interleukin	NULL
3	NULL
,	NULL
and	NULL
granulocyte/macrophage	NULL
colony-stimulating	NULL
factor	NULL
,	NULL
but	NULL
not	NULL
from	NULL
interleukin	NULL
4	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
88:3314	NULL
,	NULL
1993	NULL
21	NULL
.	NULL

Satoh	NULL
T	NULL
,	NULL
Nakafuku	NULL
M	NULL
,	NULL
Kaziro	NULL
Y	NULL
:	NULL
Function	NULL
of	NULL
ras	NULL
as	NULL
a	NULL
molecular	NULL
switch	NULL
in	NULL
signal	NULL
transduction	NULL
.	NULL

J	NULL
Biot	NULL
Chem	NULL
267:24149	NULL
,	NULL
1992	NULL
22	NULL
.	NULL

Okuda	NULL
K	NULL
,	NULL
Sanghera	NULL
JS	NULL
,	NULL
Pelech	NULL
SL	NULL
,	NULL
Kanakura	NULL
Y	NULL
,	NULL
Hallek	NULL
M	NULL
,	NULL
Griffin	NULL
JD	NULL
,	NULL
Druker	NULL
BJ	NULL
:	NULL
Granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
,	NULL
interleukin-3	NULL
,	NULL
and	NULL
steel	NULL
factor	NULL
induce	NULL
rapid	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
p42	NULL
and	NULL
p44	NULL
MAP	NULL
kinase	NULL
.	NULL

Blood	NULL
79:2880	NULL
,	NULL
1992	NULL
23	NULL
.	NULL

Gomez	NULL
Cambronero	NULL
J	NULL
,	NULL
Colasanto	NULL
JM	NULL
,	NULL
Huang	NULL
CK	NULL
,	NULL
Sha'afi	NULL
RI	NULL
:	NULL
Direct	NULL
stimulation	NULL
by	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
microtubule	NULL
associated	NULL
protein	NULL
(	NULL
MAP	NULL
)	NULL
kinase	NULL
activity	NULL
by	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
in	NULL
human	NULL
neutrophils	NULL
.	NULL

Biochem	NULL
J	NULL
291:211	NULL
,	NULL
1993	NULL
24	NULL
.	NULL

Hanazono	NULL
Y	NULL
,	NULL
Chiba	NULL
S	NULL
,	NULL
Sasaki	NULL
K	NULL
,	NULL
Mano	NULL
H	NULL
,	NULL
Miyajima	NULL
A	NULL
,	NULL
Arai	NULL
KI	NULL
,	NULL
Yazaki	NULL
Y	NULL
,	NULL
Hirai	NULL
H	NULL
:	NULL
c-fps/fes	NULL
protein-tyrosine	NULL
kinase	NULL
is	NULL
implicated	NULL
in	NULL
a	NULL
signaling	NULL
pathway	NULL
triggered	NULL
by	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
and	NULL
interleukin-3	NULL
.	NULL

EMBO	NULL
J	NULL
12:1641	NULL
,	NULL
1993	NULL
25	NULL
.	NULL

Torigoe	NULL
T	NULL
,	NULL
O'Connor	NULL
R	NULL
,	NULL
Santoli	NULL
D	NULL
,	NULL
Reed	NULL
JC	NULL
:	NULL
Interleukin-3	NULL
regulates	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
LYN	NULL
protein-tyrosine	NULL
kinase	NULL
in	NULL
myeloid-commited	NULL
leukemic	NULL
cell	NULL
lines	NULL
.	NULL

Blood	NULL
80:617	NULL
,	NULL
1992	NULL
26	NULL
.	NULL

Silvennoinen	NULL
O	NULL
,	NULL
Witthuhn	NULL
BA	NULL
,	NULL
Quelle	NULL
FW	NULL
,	NULL
Cleveland	NULL
JL	NULL
,	NULL
Yi	NULL
T	NULL
,	NULL
Ihle	NULL
JN	NULL
:	NULL
Structure	NULL
of	NULL
the	NULL
murine	NULL
JAK2	NULL
protein-tyrosine	NULL
kinase	NULL
and	NULL
its	NULL
role	NULL
in	NULL
interleukin	NULL
3	NULL
signal	NULL
transduction	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
90:8429	NULL
,	NULL
1993	NULL
27	NULL
.	NULL

Thle	NULL
JN	NULL
,	NULL
Witthuhn	NULL
BA	NULL
,	NULL
Quelle	NULL
FW	NULL
,	NULL
Yamamoto	NULL
K	NULL
,	NULL
Thierfelder	NULL
WE	NULL
,	NULL
Kreider	NULL
B	NULL
,	NULL
Silvennoinen	NULL
O	NULL
:	NULL
Signaling	NULL
by	NULL
the	NULL
cytokine	NULL
receptor	NULL
superfamily	NULL
:	NULL
JAKs	NULL
and	NULL
STAT	NULL
's	NULL
.	NULL

Trends	NULL
Biochem	NULL
Sci	NULL
19:222	NULL
,	NULL
1994	NULL
28	NULL
.	NULL

Fu	NULL
XY	NULL
,	NULL
Kessler	NULL
DS	NULL
,	NULL
Veals	NULL
SA	NULL
,	NULL
Levy	NULL
DE	NULL
,	NULL
Darnell	NULL
JE	NULL
Jr	NULL
:	NULL
ISGF3	NULL
,	NULL
the	NULL
transcriptional	NULL
activator	NULL
induced	NULL
by	NULL
interferon	NULL
a	NULL
consists	NULL
of	NULL
multiple	NULL
interacting	NULL
polypeptide	NULL
chains	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
87:8555	NULL
,	NULL
1990	NULL
29	NULL
.	NULL

Akira	NULL
S	NULL
,	NULL
Nishio	NULL
Y	NULL
,	NULL
Inoue	NULL
M	NULL
,	NULL
Wang	NULL
XJ	NULL
,	NULL
Wei	NULL
S	NULL
,	NULL
Matsusaka	NULL
T	NULL
,	NULL
Yoshida	NULL
K	NULL
,	NULL
Sudo	NULL
T	NULL
,	NULL
Naruto	NULL
M	NULL
,	NULL
Kishimoto	NULL
T	NULL
:	NULL
Molecular	NULL
cloning	NULL
of	NULL
APRF	NULL
,	NULL
a	NULL
novel	NULL
IFN-stimulated	NULL
gene	NULL
factor	NULL
3	NULL
p91-related	NULL
transcription	NULL
factor	NULL
involved	NULL
in	NULL
the	NULL
gp130-mediated	NULL
signaling	NULL
pathway	NULL
.	NULL

Cell	NULL
77:63	NULL
,	NULL
1994	NULL
30	NULL
.	NULL

Zhong	NULL
Z	NULL
,	NULL
Wen	NULL
Z	NULL
,	NULL
Darnell	NULL
JE	NULL
Jr	NULL
:	NULL
Stat3	NULL
and	NULL
stat4	NULL
:	NULL
Members	NULL
of	NULL
the	NULL
family	NULL
of	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
91:4806	NULL
,	NULL
1994	NULL
31	NULL
.	NULL

Wakao	NULL
H	NULL
,	NULL
Gouilleux	NULL
F	NULL
,	NULL
Groner	NULL
B	NULL
:	NULL
Mammary	NULL
gland	NULL
factor	NULL
(	NULL
MGF	NULL
)	NULL
is	NULL
a	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
cytokine	NULL
regulated	NULL
transcription	NULL
factor	NULL
gene	NULL
family	NULL
and	NULL
confers	NULL
the	NULL
prolactin	NULL
response	NULL
.	NULL

EMBO	NULL
J	NULL
13:2182	NULL
,	NULL
1994	NULL
32	NULL
.	NULL

Darnell	NULL
JE	NULL
Jr	NULL
,	NULL
Kerr	NULL
IM	NULL
,	NULL
Stark	NULL
GR	NULL
:	NULL
Jak-stat	NULL
pathways	NULL
and	NULL
transcriptional	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
IFNs	NULL
and	NULL
other	NULL
extracellular	NULL
signaling	NULL
proteins	NULL
.	NULL

Science	NULL
264:1415	NULL
,	NULL
1994	NULL
33	NULL
.	NULL

Caldenhoven	NULL
E	NULL
,	NULL
Coffer	NULL
P	NULL
,	NULL
Yuan	NULL
J	NULL
,	NULL
van	NULL
de	NULL
Stolpe	NULL
A	NULL
,	NULL
Horn	NULL
F	NULL
,	NULL
Kruijer	NULL
W	NULL
,	NULL
van	NULL
der	NULL
Saag	NULL
PT	NULL
:	NULL
Stimulation	NULL
of	NULL
the	NULL
human	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
promotor	NULL
by	NULL
interleukin-6	NULL
and	NULL
interferon-y	NULL
involves	NULL
binding	NULL
of	NULL
distinct	NULL
factors	NULL
to	NULL
a	NULL
palindromic	NULL
response	NULL
element	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
269:21146	NULL
,	NULL
1994	NULL
34	NULL
.	NULL

Koenderman	NULL
L	NULL
,	NULL
Kok	NULL
PT	NULL
,	NULL
Hamelink	NULL
ML	NULL
,	NULL
Verhoeven	NULL
AJ	NULL
,	NULL
Bruijnzeel	NULL
PLB	NULL
:	NULL
An	NULL
improved	NULL
method	NULL
for	NULL
the	NULL
isolation	NULL
of	NULL
eosino-philic	NULL
granulocytes	NULL
from	NULL
peripheral	NULL
blood	NULL
of	NULL
normal	NULL
individuals	NULL
.	NULL

J	NULL
Leukoc	NULL
Biol	NULL
44:79	NULL
,	NULL
1988	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1448	NULL
35	NULL
.	NULL

Hansel	NULL
TT	NULL
,	NULL
Pound	NULL
JD	NULL
,	NULL
Pilling	NULL
D	NULL
,	NULL
Kitas	NULL
GD	NULL
,	NULL
Salmon	NULL
M	NULL
,	NULL
Gentle	NULL
TA	NULL
,	NULL
Lee	NULL
SS	NULL
,	NULL
Thompson	NULL
RA	NULL
:	NULL
Purification	NULL
of	NULL
human	NULL
blood	NULL
eosinophils	NULL
by	NULL
negative	NULL
selection	NULL
using	NULL
immunomagnetic	NULL
beads	NULL
.	NULL

J	NULL
Immunol	NULL
Methods	NULL
122:97	NULL
,	NULL
1989	NULL
36	NULL
.	NULL

Hartnell	NULL
A	NULL
,	NULL
Kay	NULL
AB	NULL
,	NULL
Wardlaw	NULL
AJ	NULL
:	NULL
IFN-y	NULL
induces	NULL
expression	NULL
of	NULL
Fe	NULL
y	NULL
RIII	NULL
(	NULL
CD16	NULL
)	NULL
on	NULL
human	NULL
eosinophils	NULL
.	NULL

J	NULL
Immunol	NULL
148	NULL
:	NULL
1471	NULL
,	NULL
1992	NULL
37	NULL
.	NULL

Yazdanbakhsh	NULL
M.	NULL
Eckmann	NULL
CM	NULL
,	NULL
Roos	NULL
D	NULL
:	NULL
Characterization	NULL
of	NULL
the	NULL
interaction	NULL
of	NULL
human	NULL
eosinophils	NULL
and	NULL
neutrophils	NULL
with	NULL
opsonized	NULL
particles	NULL
.	NULL

J	NULL
Immunol	NULL
135:1378	NULL
,	NULL
1985	NULL
38	NULL
.	NULL

Andrews	NULL
NC	NULL
,	NULL
Faller	NULL
DV	NULL
:	NULL
A	NULL
rapid	NULL
micropreparation	NULL
technique	NULL
for	NULL
extraction	NULL
of	NULL
DNA-binding	NULL
proteins	NULL
from	NULL
limiting	NULL
numbers	NULL
of	NULL
mammalian	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
19:2499	NULL
,	NULL
1991	NULL
39	NULL
.	NULL

Shuai	NULL
K	NULL
,	NULL
Stark	NULL
GR	NULL
,	NULL
Kerr	NULL
IM	NULL
,	NULL
Darnell	NULL
JE	NULL
Jr	NULL
:	NULL
;	NULL
A	NULL
single	NULL
phosphotyrosine	NULL
residue	NULL
of	NULL
stat91	NULL
required	NULL
for	NULL
gene	NULL
activation	NULL
by	NULL
interferon-y	NULL
.	NULL

Science	NULL
261:1744	NULL
,	NULL
1993	NULL
VAN	NULL
DER	NULL
BRUGGEN	NULL
ET	NULL
AL	NULL
40	NULL
.	NULL

Lamb	NULL
P	NULL
,	NULL
Kessler	NULL
LV	NULL
,	NULL
Suto	NULL
C	NULL
,	NULL
Levy	NULL
DE	NULL
,	NULL
Seidel	NULL
!	NULL

HM	NULL
,	NULL
Stein	NULL
RB	NULL
,	NULL
Rosen	NULL
J	NULL
:	NULL
Rapid	NULL
activation	NULL
of	NULL
proteins	NULL
that	NULL
interact	NULL
with	NULL
the	NULL
interferon	NULL
y	NULL
activation	NULL
site	NULL
in	NULL
response	NULL
to	NULL
multiple	NULL
cytokines	NULL
.	NULL

Blood	NULL
83:2063	NULL
,	NULL
1994	NULL
41	NULL
.	NULL

Larner	NULL
AC	NULL
,	NULL
David	NULL
M	NULL
,	NULL
Feldman	NULL
GM	NULL
,	NULL
Igarashi	NULL
K	NULL
,	NULL
Hackett	NULL
RH	NULL
.	NULL

Webb	NULL
DSA	NULL
,	NULL
Sweitzer	NULL
SM	NULL
,	NULL
Petricoin	NULL
EF	NULL
III	NULL
,	NULL
Finbloom	NULL
DS	NULL
:	NULL
Tyrosine	NULL
phosphorylation	NULL
of	NULL
DNA	NULL
binding	NULL
proteins	NULL
by	NULL
multiple	NULL
cytokines	NULL
.	NULL

Science	NULL
261:1730	NULL
,	NULL
1993	NULL
42	NULL
.	NULL

Matsuda	NULL
T	NULL
,	NULL
Hirano	NULL
T	NULL
:	NULL
Association	NULL
of	NULL
p72	NULL
tyrosine	NULL
kinase	NULL
with	NULL
Stat	NULL
factors	NULL
and	NULL
its	NULL
activation	NULL
by	NULL
interleukin-3	NULL
,	NULL
interleukin-6	NULL
,	NULL
and	NULL
granulocyte	NULL
colony-stimulating	NULL
factor	NULL
.	NULL

Blood	NULL
§3:3457	NULL
,	NULL
1994	NULL
43	NULL
.	NULL

Riedel	NULL
D	NULL
,	NULL
Lindemann	NULL
A	NULL
,	NULL
Brach	NULL
M	NULL
,	NULL
Mertelsmann	NULL
R	NULL
,	NULL
Herrmann	NULL
F	NULL
:	NULL
Granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
and	NULL
interleukin-3	NULL
induce	NULL
surface	NULL
expression	NULL
of	NULL
interleukin-2	NULL
receptor	NULL
p55-chain	NULL
and	NULL
CD4	NULL
by	NULL
human	NULL
eosinophils	NULL
.	NULL

Immunology	NULL
70:258	NULL
,	NULL
1990	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
blO	NULL
0d	NULL
1995	NULL
85	NULL
:	NULL
1442-1448	NULL
Interleukin-5	NULL
signaling	NULL
in	NULL
human	NULL
eosinophils	NULL
involves	NULL
JAK2	NULL
tyrosine	NULL
kinase	NULL
and	NULL
Stati	NULL
alpha	NULL
4	NULL
_	NULL
5	NULL
,	NULL
'	NULL
_	NULL
>	NULL
,	NULL
#	NULL
04	NULL
;	NULL
@	NULL
``	NULL
20	NULL
T	NULL
van	NULL
der	NULL
Bruggen	NULL
,	NULL
E	NULL
Caldenhoven	NULL
,	NULL
D	NULL
Kanters	NULL
,	NULL
P	NULL
Coffer	NULL
,	NULL
JA	NULL
Raaijimakers	NULL
,	NULL
JW	NULL
Lammers	NULL
and	NULL
L	NULL
Koenderman	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/85/6/1442.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

